NeuroPace Inc (NPCE) stock

NPCENasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/3077% above fair value

$12.02−0.50 (-3.99%)

Close on Nov 12, 2026Market cap $412.58MP/E –Yield 0.00%

NeuroPace statistics

88 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: Q3 FY2026, expected soon
Last ex-dividend date: No dividends
Fundamentals through: Sep 30, 2026
Share price as of: Nov 12, 2026

Valuation ratiosIndustry

Market Cap: $412.58M; $501.02M
Enterprise Value: $422.54M; $422.54M
PS Ratio: 3.86; 3.03
PB Ratio: 35.90; 3.29
P/TBV Ratio: 35.90; 4.85

Enterprise valuationIndustry

EV / Sales: 3.96; 2.70

Share statisticsIndustry

Shares Outstanding: 34M; 43M
Shares Change (YoY): 6.41%; 3.22%
Shares Change (QoQ): 0.44%; 0.16%
Float: 29M; 37M
Shares Held by Insiders: 16.6%; 10.5%
Shares Held by Institutions: 77.4%; 60.2%

Short sellingIndustry

Short Interest: 858,343; –
Short Interest Change: -3.15%; -2.57%
Short % of Float: 3.00%; 5.12%
Short % of Shares Outstanding: 2.50%; 3.98%
Days to Cover: 8.48; 3.94

Stock price statisticsIndustry

52-Week High: $19.60; –
52-Week Low: $11.90; –
20-Day Moving Average: $12.77; –
50-Day Moving Average: $13.35; –
200-Day Moving Average: $14.80; –
Average True Range (14): $0.69; –
Price Change (1 Week): -5.28%; 1.87%
Price Change (1 Month): -4.30%; -0.57%
Price Change (3 Months): -18.6%; -7.91%
Price Change (6 Months): -23.9%; -0.90%
Price Change (YTD): -22.2%; -0.87%
Price Change (1 Year): -10.9%; -1.18%
Price Change (3 Years): 41.6%; 6.56%
Price Change (5 Years): -14.1%; -49.8%
Average Volume (10 Days): 149,493; –
Average Volume (20 Days): 127,272; –
Average Volume (90 Days): 154,909; –
Relative Volume: 1.01; 0.82
Relative Strength Index (14): 40.7; 47.7
Volatility (1 Year): 50.7%; 64.2%
Beta (5 Years): 1.05; 1.04

MarginsIndustry

Gross Margin: 77.8%; 55.9%
Operating Margin: -9.51%; -5.17%
Profit Margin: -17.7%; -9.23%
EBITDA Margin: -9.51%; -2.82%
FCF Margin: -11.6%; 0.40%

Returns on capitalIndustry

Return on Equity (ROE): -126.1%; -17.1%
Return on Assets (ROA): -18.7%; -12.2%
Return on Invested Capital (ROIC): -41.4%; -3.22%
Return on Capital Employed (ROCE): -12.9%; -8.13%

Financial positionIndustry

Current Ratio: 5.26; 2.45
Quick Ratio: 3.95; 1.53
Debt / Equity: 5.15; 0.42
Interest Coverage: -1.63; -1.68

GrowthIndustry

Revenue Growth (YoY): 23.0%; 9.24%
Revenue Growth (3Y CAGR): 30.0%; 7.08%
Revenue Growth (5Y CAGR): 19.4%; 11.8%

EfficiencyIndustry

Asset Turnover: 1.06; 0.59
Inventory Turnover: 1.28; 2.20
Revenue Per Employee: $511.06K; $330.60K
Profits Per Employee: -$90.51K; -$41.39K
Employee Count: 209; 186
WACC: 9.99%; 9.79%

Income statement (TTM)Industry

Revenue: $106.81M; $106.81M
Gross Profit: $83.13M; $62.29M
Operating Income: -$10.16M; -$3.72M
Net Income: -$18.92M; -$6.19M
EBITDA: -$10.16M; -$1.98M
EPS (Diluted): -$0.56; -$0.08

Balance sheetIndustry

Cash & Short-Term Investments: $49.20M; $38.08M
Total Debt: $59.16M; $96.00M
Net Cash (Debt): -$9.96M; $3.73M
Net Cash Per Share: -$0.29; $0.24
Equity (Book Value): $11.49M; $63.44M
Book Value Per Share: $0.33; $3.26
Tangible Book Value: $11.49M; $11.04M
Working Capital: $68.47M; $56.85M

Cash flow (TTM)Industry

Operating Cash Flow: -$12.06M; -$541.49K
Capital Expenditures: -$355.00K; -$3.69M
Free Cash Flow: -$12.42M; -$387.37K
FCF Per Share: -$0.36; -$0.01

Dividends and yieldsIndustry

Earnings Yield: -4.58%; -4.70%
FCF Yield: -3.01%; 0.24%
Dividend Yield: 0.00%; 0.80%
Buyback Yield: 0.00%; 0.79%
Shareholder Yield: 0.00%; 1.05%
Dividend Per Share: $0.00; $0.72
Years of Dividend Growth: 0; 0

Taxes and interestIndustry

Interest Expense: $6.23M; $5.33M

Scores and fair valueIndustry

Altman Z-Score: -3.79; 2.44
Piotroski F-Score: 5; 5

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.

Period	NPCE	S&P 500	Difference	NPCE per year	S&P 500 per year
1 month	-7.5%	-2.7%	−4.8 pts
3 months	-17.4%	-1.7%	−15.7 pts
Year to date	-22.2%	+11.9%	−34.0 pts
1 year	-11.0%	+12.0%	−22.9 pts
3 years	+53.1%	+78.2%	−25.1 pts	+15.3%	+21.2%
5 years	-14.1%	+73.2%	−87.4 pts	-3.0%	+11.6%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

1M NPCE shares were sold short on Oct 30, 2026, down 3.1% from the previous report, or 3.00% of the shares available to trade. At recent volumes it would take 8.5 days to buy them back. Over the last 20 sessions, 47.6% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	858,343	-3.1%	101,274	8.5
Oct 15, 2026	886,230	-1.9%	107,138	8.3
Sep 30, 2026	903,626	-5.5%	146,303	6.2
Sep 15, 2026	956,221	+4.9%	109,736	8.7
Aug 31, 2026	911,415	+7.8%	145,058	6.3
Aug 14, 2026	845,369	+2.8%	253,466	3.3
Jul 31, 2026	822,126	-6.0%	208,764	3.9
Jul 15, 2026	874,337	-2.7%	153,268	5.7
Jun 30, 2026	898,587	+46.6%	228,821	3.9
Jun 15, 2026	612,829	+5.1%	137,787	4.5
May 29, 2026	582,943	-5.0%	148,704	3.9
May 15, 2026	613,817	-20.7%	266,324	2.3